$ Value
—
Shares
50
Price
—
Filed
Mar 23
Insider
Name
Duvall Diantha
Title
CFO
CIK
0001696784
Roles
Transaction Details
Transaction Date
2026-03-20
Code
C
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each share of Series B Convertible Non-Redeemable Preferred Stock ("Series B Preferred Stock") automatically converted into 1,333.33 shares of Common Stock, for no additional consideration, at 5 p. m. Eastern Time on March 20, 2026, subject to the terms of the Certificate of Designations, Preferences and Rights of Series B Convertible Non-Redeemable Preferred Stock of Curis, Inc. (the "Certificate of Designations") and subject to the applicable Beneficial Ownership Limitations (as defined in the Certificate of Designations). Each share of Series B Preferred Stock was sold together with a Series A Warrant to purchase 1,333.33 shares of Common Stock, a Series B Warrant to purchase 1,333.33 shares of Common Stock and a Series C Warrant to purchase 1,333.33 shares of Common Stock (collectively, a "Security"). The Securities were sold at a purchase price of $1,000.00 per Security to the Reporting Person.
Filing Info
Duvall Diantha's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-20 | CRIS | C | — |
| 2026-03-20 | CRIS | C | — |
| 2026-03-17 | CRIS | A | — |
| 2026-03-17 | CRIS | A | — |
| 2026-03-17 | CRIS | A | — |
| 2026-03-17 | CRIS | A | — |
| 2025-05-20 | CRIS | A | $423K |
Other Insiders at CRIS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| KAITIN KENNETH I | $5K | — | 2026-03-31 |
|
Dentzer James E
President & CEO
|
— | — | 2026-03-20 |
| Rubin Marc | — | — | 2026-03-20 |
|
Hamdy Ahmed MD
CMO
|
— | — | 2026-03-20 |
|
Duvall Diantha
CFO
|
— | — | 2026-03-20 |
|
Zung Jonathan B.
CDO
|
— | — | 2026-03-20 |